TrialPloS one2018

Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers.

Marie N S Gendy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.